Haplotype effect in the IGF1 promoter accounts for the association between microsatellite and serum IGF1 concentration

Clinical Endocrinology

Volumn 74, Issue 4, 2011, Pages 520-527

  Chen, Holly Y ^a   Chan, Iris H S ^a   Sham, Aprille L K ^b   Leung, Vincent H K ^a   Ma, Suk L ^c   Ho, Suzanne C ^b   Tang, Nelson L S ^a,b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CHINESE; COHORT ANALYSIS; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MENARCHE; MICROSATELLITE MARKER; PREMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST HIP RATIO;

ADULT; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LINKAGE DISEQUILIBRIUM; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79952380146     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03962.x     Document Type: Article

References (35)

1. Pollak, M., (2000) Insulin-like growth factor physiology and cancer risk. European Journal of Cancer, 36, 1224-1228. (Pubitemid 30407009)
2. Mahmoudabady, M., Mathieu, M., Touihri, K., et al. (2009) Cardiac insulin-like growth factor-1 and cyclins gene expression in canine models of ischemic or overpacing cardiomyopathy. BMC Cardiovascular Disorders, 9, 49.
3. Musaro, A., Dobrowolny, G., &, Rosenthal, N., (2007) The neuroprotective effects of a locally acting IGF-1 isoform. Experimental Gerontology, 42, 76-80. (Pubitemid 44937819)
4. Pollak, M.N., Schernhammer, E.S., &, Hankinson, S.E., (2004) Insulin-like growth factors and neoplasia. Nature Reviews Cancer, 4, 505-518. (Pubitemid 38868620)
5. Tatar, M., Bartke, A., &, Antebi, A., (2003) The endocrine regulation of aging by insulin-like signals. Science, 299, 1346-1351. (Pubitemid 36254639)
6. Wilkinson-Berka, J.L., Wraight, C., &, Werther, G., (2006) The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Current Medicinal Chemistry, 13, 3307-3317. (Pubitemid 44669777)
7. Bichell, D.P., Kikuchi, K., &, Rotwein, P., (1992) Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo. Molecular Endocrinology, 6, 1899-1908.
8. Eleswarapu, S., Ge, X., Wang, Y., et al. (2009) Growth hormone-activated STAT5 may indirectly stimulate IGF-I gene transcription through HNF-3{gamma}. Molecular Endocrinology, 23, 2026-2037.
9. Patel, A.V., Cheng, I., Canzian, F., et al. (2008) IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS ONE, 3, e2578.
10. Palmqvist, R., Hallmans, G., Rinaldi, S., et al. (2002) Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut, 50, 642-646. (Pubitemid 34407490)
11. Kehinde, E.O., Akanji, A.O., Mojiminiyi, O.A., et al. (2005) Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men. Prostate Cancer and Prostatic Diseases, 8, 84-90.
12. DeLellis, K., Ingles, S., Kolonel, L., et al. (2003) IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. British Journal of Cancer, 88, 277-282. (Pubitemid 36255848)
13. Shishko, P.I., Dreval, A.V., Abugova, I.A., et al. (1994) Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion. Diabetes Research and Clinical Practice, 25, 1-12. (Pubitemid 24288040)
14. Palles, C., Johnson, N., Coupland, B., et al. (2008) Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. Human Molecular Genetics, 17, 1457-1464. (Pubitemid 351627342)
15. Rodriguez-Galindo, C., Poquette, C.A., Daw, N.C., et al. (2001) Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma. Medical and Pediatric Oncology, 36, 605-611. (Pubitemid 32402156)
16. Colao, A., Di Somma, C., Cascella, T., et al. (2008) Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. European Journal of Endocrinology, 159, 389-397.
17. Barbieri, M., Paolisso, G., Kimura, M., et al. (2009) Higher circulating levels of IGF-1 are associated with longer leukocyte telomere length in healthy subjects. Mechanisms of Ageing and Development, 130, 771-776.
18. Cheng, I., DeLellis Henderson, K., Haiman, C.A., et al. (2007) Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population. Journal of Clinical Endocrinology and Metabolism, 92, 3660-3666. (Pubitemid 47435353)
19. Wu, M., Hall, J.B., Akers, R.M., et al. (2010) Effect of feeding level on serum IGF1 response to GH injection. Journal of Endocrinology, 206, 37-45.
20. Al-Zahrani, A., Sandhu, M.S., Luben, R.N., et al. (2006) IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Human Molecular Genetics, 15, 1-10. (Pubitemid 43020099)
21. Meng, Z., Zaykin, D.V., Xu, C.F., et al. (2003) Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes. American Journal of Human Genetics, 73, 115-130. (Pubitemid 36793785)
22. Tang, N.L., Liao, C.D., Ching, J.K., et al. (2010) Sex-specific effect of Pirin gene on bone mineral density in a cohort of 4000 Chinese. Bone, 46, 543-550.
23. Guo, D.C., &, Milewicz, D.M., (2003) Methodology for using a universal primer to label amplified DNA segments for molecular analysis. Biotechnological Letters, 25, 2079-2083. (Pubitemid 38092565)
24. de Arruda, M.P., Goncalves, E.C., Schneider, M.P., et al. (2010) An alternative genotyping method using dye-labeled universal primer to reduce unspecific amplifications. Molecular Biology Reports, 37, 2031-2036.
25. Stephens, M., Smith, N.J., &, Donnelly, P., (2001) A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics, 68, 978-989. (Pubitemid 32289743)
26. Li, L., Cicek, M.S., Casey, G., et al. (2004) No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer. Cancer Epidemiology, Biomarkers and Prevention, 13, 497-498. (Pubitemid 38737479)
27. Serre, D., Gurd, S., Ge, B., et al. (2008) Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genetics, 4, e1000006.
28. Cleveland, R.J., Gammon, M.D., Edmiston, S.N., et al. (2006) IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis, 27, 758-765.
29. Missmer, S.A., Haiman, C.A., Hunter, D.J., et al. (2002) A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. International Journal of Cancer, 100, 332-336. (Pubitemid 34728992)
30. Fehringer, G., Ozcelik, H., Knight, J.A., et al. (2009) Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women. Breast Cancer Research and Treatment, 116, 413-423.
31. Jernstrom, H., Chu, W., Vesprini, D., et al. (2001) Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Molecular Genetics and Metabolism, 72, 144-154. (Pubitemid 34171454)
32. Biong, M., Gram, I.T., Brill, I., et al. (2010) Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density. BMC Medical Genomics, 3, 9.
33. Dewell, A., Weidner, G., Sumner, M.D., et al. (2007) Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial. Nutrition and Cancer, 58, 35-42. (Pubitemid 47076160)
34. Haydon, A.M., Macinnis, R.J., English, D.R., et al. (2006) Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer. Gut, 55, 689-694.
35. Franceschi, C., Olivieri, F., Marchegiani, F., et al. (2005) Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mechanisms of Ageing and Development, 126, 351-361. (Pubitemid 40038357)